The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
884
November 27, 1992
View Complete Issue         Table of Contents 2019 
Cefpodoxime Proxetil - A New Oral Cephalosporin
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Cefpodoxime Proxetil - A New Oral Cephalosporin
November 27, 1992 (Issue: 884)
Cefpodoxime proxetil (Vantin - Upjohn), a new third-generation oral cephalosporin, has been approved for marketing by the US Food and Drug Administration. It is available for twice-daily treatment of pharyngitis, upper and lower respiratory...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Cefpodoxime Proxetil - A New Oral Cephalosporin
Article code: 884a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.